Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy
Carlos González-Cruz, MD,
Eva Muñoz-Couselo, MD, PhD,
Carolina Ortiz-Velez, MD,
Berta Ferrer, MD,
Vicente García-Patos, MD, PhD,
Carla Ferrándiz-Pulido, MD, PhD
Affiliations
Carlos González-Cruz, MD
Department of Dermatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Facultad de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain; Correspondence to: Carla Ferrándiz-Pulido, MD, PhD, Department of Dermatology, Hospital Universitari Vall d’Hebron, Passeig de la Vall d’Hebron, 119, 08035 Barcelona, Spain.
Eva Muñoz-Couselo, MD, PhD
Department of Medical Oncology, Vall d’Hebron Institute of Oncology, Hospital Universitari Vall d’Hebron, Barcelona Spain
Carolina Ortiz-Velez, MD
Department of Medical Oncology, Vall d’Hebron Institute of Oncology, Hospital Universitari Vall d’Hebron, Barcelona Spain
Berta Ferrer, MD
Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Vicente García-Patos, MD, PhD
Department of Dermatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Facultad de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
Carla Ferrándiz-Pulido, MD, PhD
Department of Dermatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Facultad de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain